ASSET PURCHASE AGREEMENTAsset Purchase Agreement • June 2nd, 2020 • Predictive Oncology Inc. • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
Contract Type FiledJune 2nd, 2020 Company Industry JurisdictionThis Asset Purchase Agreement (“Agreement”), dated as of May 27, 2020, is entered into by and among InventaBioTech, Inc., a Colorado corporation (“Seller”), Soluble Therapeutics, Inc., a Delaware corporation (“Soluble”), BioDtech, Inc., a Delaware corporation (“BioDtech”) (collectively, Soluble, and BioDtech are the “Subsidiaries,” with Seller, the “Selling Parties”), and Predictive Oncology Inc., a Delaware corporation (“Buyer”).